Table 1 Clinicopathological characteristics of CRC patients according to UTX expression
From: CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression
| Â | UTX expression | Â | |
|---|---|---|---|
|  | High group (n = 104), % | Low group (n = 156), % | P valuve |
Characteristics | Â | Â | Â |
Age | Â | Â | 0.325 |
  ≤ 60 | 67 (42.4) | 91 (57.6) |  |
  > 60 | 37 (36.3) | 65 (63.7) |  |
Gender | Â | Â | 0.003 |
 Male | 52 (32.7) | 107 (67.3) |  |
 Female | 52 (51.5) | 49 (48.5) |  |
Tumor Location | Â | Â | 0.085 |
 Colon | 42 (34.4) | 80 (65.6) |  |
 Rectum | 62 (44.9) | 76 (55.1) |  |
Preoperative Serum CEA | Â | Â | 0.916 |
 Elevated | 36 (40.0) | 54 (60.0) |  |
 Normal | 65 (40.4) | 96 (59.6) |  |
 Unknown | 3 (33.3) | 6 (66.7) |  |
pT stage | Â | Â | 0.045 |
 2 | 23 (56.1) | 18 (43.9) |  |
 3 | 23 (42.6) | 31 (57.4) |  |
 4 | 58 (35.2) | 107 (64.8) |  |
pN stage | Â | Â | 0.743 |
 0 | 48 (42.1) | 66 (57.9) |  |
 1 | 27 (36.5) | 47 (63.5) |  |
 2 | 29 (40.3) | 43 (59.7) |  |
TNM stage | Â | Â | 0.283 |
 I | 12 (60.0) | 8 (40.0) |  |
 II | 28 (36.4) | 49 (63.6) |  |
 III | 48 (39.0) | 75 (61.0) |  |
 IV | 16 (40.0) | 24 (60.0) |  |
Historical type | Â | Â | 1.000 |
 Adenocarcinoma | 98 (40.0) | 147 (60.0) |  |
 Mucinous adenocarcinoma | 6 (40.0) | 9 (60.0) |  |
Grade | Â | Â | 0.499 |
 Well-Moderately differentiated | 77 (40.7) | 112 (59.3) |  |
 Moderately-Poor differentiated | 19 (34.5) | 36 (65.5) |  |
 Unknown | 8 (50.0) | 8 (50.0) |  |
Vessel Invasion | Â | Â | 0.408 |
 Yes | 39 (45.3) | 47 (54.7) |  |
 No | 64 (37.6) | 106 (62.4) |  |
 Unknown | 1 (25.0) | 3 (75.0) |  |
Nerve Invasion | Â | Â | 0.404 |
 Yes | 14 (34.1) | 27 (65.9) |  |
 No | 90 (41.1) | 129 (58.9) |  |